BlinkLab Limited focuses on the development and commercialization of intellectual property related to smartphone-neurobehavioral testing. The company's smartphone-based application serves as a device for conducting neurobehavioral evaluations. Its application also enables remote and rapid testing to aid research on neurodevelopmental and neurodegenerative conditions such as schizophrenia, autism, attention deficit hyperactivity disorder (ADHD), and various forms of dementia. The company was incorporated in 2021 and is based in Sydney, Australia.
Health Information Services
Healthcare
Get real-time and historical exchange rates for any currency!
Get real-time and historical stock ticker prices for US stocks!
Translate cryptic bank transactions into merchants with logos, address and more!
Brought to you by Synth, a modern fintech API for modern businesses